Yang Ying

ACF Cover Figure · New Business Leader | Yang Ying: From Private School to STAR Market — Building a 10-Billion "Education + Pharma + Real Estate" Empire

Asia "Cover Figure" · New Business Leader | Issue No. 047 — ACF-XLX-2026

Summary: In 1994, she founded Xiamen Yingcai School. In 1997, she invested in Amoytop Biotech. In 2001, she entered Beijing real estate. In 2020, Amoytop Biotech listed on the STAR Market. In 2025, she topped the Zhangzhou richest list with a fortune of 13 billion RMB, having donated over 76 million cumulatively. From private education to a biomedical leader, she built a hundred-billion empire spanning education, pharma, and real estate.

In 2020, Fujian's homegrown biopharmaceutical company Amoytop Biotech successfully listed on the STAR Market, becoming an important benchmark enterprise in regional biomedical industry development through its hardcore biological innovation technology. The company's steady growth would not have been possible without Yang Ying, the core operator who cultivated the industry for years.

The public knows her 2025 ranking near the top of regional wealth lists, but few understand the complete path of her thirty years of industry cultivation. In 1994, Yang Ying's career formally began — entering the market through a private school in Xiamen, taking root in the real economy, rejecting short-term traffic and opportunistic speculation. Through decades of steady deployment, she successively launched biomedical and urban real estate operations, building a diversified industrial system with education, pharma, and real estate working in synergy, consolidating her industrial foundation and industry position through long-termist business thinking.

I. Education Origins: One School, One Starting Point

In the 1990s, China's private education industry was still in its infancy. Market-oriented schooling models were not yet widespread, and the industry lacked mature operational systems. In 1994, addressing southern Fujian's local education needs, Yang Ying founded Xiamen Yingcai School, formally entering the real-economy track.

Unlike most commercial projects pursuing rapid profit, education involves long investment cycles, slow returns, and heavy responsibility. Yang Ying did not chase short-term economic benefits — she focused on teaching system development, faculty team building, and campus infrastructure upgrades, deeply cultivating refined private education operations. Through standardized schooling and quality teaching, Xiamen Yingcai School gradually earned market and parental recognition, becoming a benchmark private school in southern Fujian.

Long-term-value industry competitiveness begins with persistence and sustained investment.

The education cultivation experience established Yang Ying's core business logic. She deeply recognized that quality industry cannot be rushed — only sustained investment, steady refinement, and long-term perseverance can build solid industry barriers. This pragmatic, stable, long-horizon operating philosophy became her core principle for subsequent cross-sector deployment into pharma and real estate, laying the initial foundation for her diversified commercial empire.

II. Cross-Sector Deployment: The Twin Wings of Pharma and Real Estate

After education operations stabilized with a mature development system, Yang Ying launched diversified industrial deployment based on precise judgment of real economy trends, strategically entering two core real-economy tracks to complete her industrial ecosystem.

In 1997, China's biomedical innovation industry was in its exploration stage. Yang Ying made a strategic investment in Amoytop Biotech, deploying ahead in the biomedical innovation track. She focused on biopharmaceutical R&D, technology innovation, and results transformation, supporting the company's research investment and team building for over twenty years.

In 2001, as urbanization advanced, Yang Ying deployed real estate, entering the Beijing market and founding Xin Yingcai Real Estate, focusing on high-quality property development. In 2007, to integrate diverse business resources, she formally established Xin Yingcai Holdings Group, consolidating education, pharma, and real estate into a synergistic, stable diversified industrial ecosystem.

After twenty-plus years, each business segment developed steadily. In 2020, Amoytop Biotech successfully listed on the STAR Market, its R&D strength and industrial value recognized by capital markets — marking a key milestone in Yang Ying's diversified deployment.

III. Giving Back: The Character Beyond Business

Thirty years of industry cultivation, Yang Ying has always maintained the pragmatic, responsible character of a Fujian businessperson. As the enterprise grew, she continuously fulfilled social responsibility, focusing on hometown construction and philanthropy.

In 2006, when Fujian's Pinghe suffered flood disasters, Yang Ying donated 3 million RMB for post-disaster reconstruction. In 2025, she invested 1.2 million in a women and children's center in Pinghe County. Over the years, her cumulative philanthropic donations reached 76.73 million RMB, with dedicated funds for serious illness relief and public welfare development.

From her roots in southern Fujian to nationwide diversified real-economy deployment and deep philanthropic giving back to hometown — Yang Ying has always cultivated industry with a steady, progressive posture. Rejecting speculative short-termism, with Fujian merchant resilience and pragmatism, she cultivates every track, accumulating every unit of value, creating industrial worth while continuously fulfilling social responsibility.

Every cover publication is registered and kept in the ACF Cover Archive. The code is permanent.

Further ReadingRelated

Wang Xingxing

ACF Code

ACF-01-00202

Wang Xingxing

Founder & CEO

Wang Ning

ACF Code

ACF-01-00153

Wang Ning

Founder & CEO

Ye Yuehui

ACF Code

ACF-01-00163

Ye Yuehui

Founder

Not Everyone Makes the Cover

Asia Cover Figure · Influencing Those Who Influence